EUSA Pharma announce acquisition of SYLVANT® from Janssen
EUSA Pharma acquires SYLVANT from Janssen for $115 million
BioIVT acquires Optivia Biotechnology
BioIVT, a provider of research models and services for drug development, has announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its...
Sanofi and Advent finalise negotiations for the acquisition of Zentiva
Sanofi and Advent International (Advent) have finished negotiations for the acquisition of Zentiva - Sanofi's European generics business. Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion...
Takeda ups bid to $65 billion in negotiations to buy Shire
Takeda has increased offer to buy Shire for a mix of stock and cash worth ~$65 billion
Merck to sell Consumer Health to Procter & Gamble
Merck has sold its global Consumer Health business to Procter & Gamble
Advent in negotiations to acquire Sanofi’s generics business
Advent and Sanofi are in negotiations under which Advent would acquire Zentiva,
Certara acquires Analytica Laser
Certara announced it has acquired Analytica Laser which uses health economics and outcomes research (HEOR)
Mylan partners with Fujifilm Kyowa Kirin Biologics
Mylan partners with Fujifilm Kyowa Kirin Biologics to commercialise a biosimilar to Humira®
GSK buys out Novartis’ stake in Consumer Healthcare
GlaxoSmithKline plc have announced that it has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint...
Nanologica & Sterling partnership furthers new business venture
Nanologica AB has entered into a service agreement with global contract development and manufacturing organisation (CDMO) Sterling Pharma Solutions for the large-scale production of...
Latest articles
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Poor diabetes control costs the NHS £3bn in avoidable treatment
New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...